School of Materials Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Shanghai Engineering Technology Research Center for High-Performance Medical Device Materials, Shanghai 200093, China.
Biomolecules. 2021 Apr 25;11(5):635. doi: 10.3390/biom11050635.
A side-by-side electrospinning process characterized by a home-made eccentric spinneret was established to produce the Janus beads-on-a-string products. In this study, ketoprofen (KET) and methylene blue (MB) were used as model drugs, which loaded in Janus beads-on-a-string products, in which polyvinylpyrrolidone K90 (PVP K90) and ethyl cellulose (EC) were exploited as the polymer matrices. From SEM images, distinct nanofibers and microparticles in the Janus beads-on-a-string structures could be observed clearly. X-ray diffraction demonstrated that all crystalline drugs loaded in Janus beads-on-a-string products were transferred into the amorphous state. ATR-FTIR revealed that the components of prepared Janus nanostructures were compatibility. In vitro dissolution tests showed that Janus beads-on-a-string products could provide typical double drugs controlled-release profiles, which provided a faster immediate release of MB and a slower sustained release of KET than the electrospun Janus nanofibers. Drug releases from the Janus beads-on-a-string products were controlled through a combination of erosion mechanism (linear MB-PVP sides) and a typical Fickian diffusion mechanism (bead KET-EC sides). This work developed a brand-new approach for the preparation of the Janus beads-on-a-string nanostructures using side-by-side electrospinning, and also provided a fresh idea for double drugs controlled release and the potential combined therapy.
一种采用自制偏心喷丝头的并列静电纺丝工艺被建立起来,以生产Janus 串珠产品。在这项研究中,酮洛芬(KET)和亚甲蓝(MB)被用作模型药物,它们负载在 Janus 串珠产品中,其中聚乙烯吡咯烷酮 K90(PVP K90)和乙基纤维素(EC)被用作聚合物基质。从 SEM 图像中,可以清楚地观察到 Janus 串珠结构中明显的纳米纤维和微粒。X 射线衍射表明,负载在 Janus 串珠产品中的所有结晶药物都转变成非晶态。ATR-FTIR 表明制备的 Janus 纳米结构的成分具有相容性。体外溶解试验表明,Janus 串珠产品可以提供典型的双重药物控制释放曲线,与静电纺丝的 Janus 纳米纤维相比,MB 具有更快的即刻释放,而 KET 则具有更缓慢的持续释放。Janus 串珠产品中的药物释放通过侵蚀机制(线性 MB-PVP 侧)和典型的菲克扩散机制(珠状 KET-EC 侧)的组合来控制。这项工作开发了一种使用并列静电纺丝制备 Janus 串珠纳米结构的全新方法,也为双重药物控制释放和潜在的联合治疗提供了新的思路。